| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2011 | EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1446401B1 C5-modified indazolylpyrrolotriazines |
| 09/14/2011 | EP1392381B9 An aerosol forming device for use in inhalation therapy |
| 09/14/2011 | EP1377551B1 Antiproliferative agents |
| 09/14/2011 | EP1358215B1 Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | EP1262555B1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/14/2011 | EP1257264B1 Estrogen receptor modulators |
| 09/14/2011 | EP1027440B2 Inhibitor protein of the wnt signal pathway |
| 09/14/2011 | DE202010017129U1 Rasagilinformulierung mit verzögerter Freisetzung Rasagilinformulierung sustained release |
| 09/14/2011 | CN1965850B Roxithromycin injection and preparation process thereof |
| 09/14/2011 | CN1918172B Rifamycin analogs and uses thereof |
| 09/14/2011 | CN1918146B Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/14/2011 | CN1906308B Cell transfecting formulations of small interfering RNA, related compositions and methods of making and use |
| 09/14/2011 | CN1898206B Allosteric modulators of metabotropic glutamate receptors |
| 09/14/2011 | CN1868508B Medicine composition, application of the same for preparing medicine to treat and prevent cardiovascular and cerebrovascular disease |
| 09/14/2011 | CN1842329B Preventive or ameliorating agent for liver disease involving hepatopathy |
| 09/14/2011 | CN1823765B Indapamide percutaneous controlled release plaster and its preparation method |
| 09/14/2011 | CN1802187B Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 09/14/2011 | CN1802179B Compositions containing piperacillin and tazobactam useful for injection |
| 09/14/2011 | CN1780623B PTEN inhibitor or MAXI-K channels opener |
| 09/14/2011 | CN1695738B Composition of medication for treating high blood pressure |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1436191B Antitumoral ecteinascidin derivatives |
| 09/14/2011 | CN102186978A Compositions and methods for inhibiting expression of transthyretin |
| 09/14/2011 | CN102186874A New NO releasing steroids derivatives |
| 09/14/2011 | CN102186873A New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 09/14/2011 | CN102186872A Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent |
| 09/14/2011 | CN102186857A Thienopyrimidines for pharmaceutical compositions |
| 09/14/2011 | CN102186856A Pyrrolopyrimidine compounds as cdk inhibitors |
| 09/14/2011 | CN102186855A Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 09/14/2011 | CN102186853A Alpha helix mimetics in the treatment of cancer |
| 09/14/2011 | CN102186852A 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186851A Triazolopyridine compounds as pim kinase inhibitors |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186848A Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 09/14/2011 | CN102186847A New 2-amidothiadiazole derivatives |
| 09/14/2011 | CN102186846A Pyridine derivative having substituted hetero ring and substituted ?-glutamylamino group, and anti-fungal agent comprising same |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186843A A process for preparation of rosuvastatin acetonide calcium |
| 09/14/2011 | CN102186842A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 09/14/2011 | CN102186841A 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
| 09/14/2011 | CN102186840A Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 09/14/2011 | CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186838A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186836A Trpv1 antagonists |
| 09/14/2011 | CN102186832A Compounds, compositions and methods of using same for modulating uric acid levels |
| 09/14/2011 | CN102186830A New benzimidazole derivatives |
| 09/14/2011 | CN102186829A Bridged tetrahydronaphthalene derivatives |
| 09/14/2011 | CN102186828A Salts of isobutyric acid (1 r*, 2r*, 4r* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 h-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl |
| 09/14/2011 | CN102186827A Compounds, compositions and methods of using same for modulating uric acid levels |
| 09/14/2011 | CN102186825A Aryl gpr120 receptor agonists and uses thereof |
| 09/14/2011 | CN102186824A Fused-ring derivative and medical application of same |
| 09/14/2011 | CN102186823A Heterocyclic antiviral arylpyridone derivatives |
| 09/14/2011 | CN102186822A Novel urea and thiourea derivatives |
| 09/14/2011 | CN102186820A Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
| 09/14/2011 | CN102186818A 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 09/14/2011 | CN102186817A Atropisomers of (hydroxyalkyl) pyrrole derivatives |
| 09/14/2011 | CN102186803A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 09/14/2011 | CN102186495A Methods of enhancing opsonophagocytosis in response to a pathogen |
| 09/14/2011 | CN102186488A Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function |
| 09/14/2011 | CN102186484A Aabb-poly(depsipeptide) biodegradable polymers and methods of use |
| 09/14/2011 | CN102186483A A micro-rna that promotes vascular integrity and uses thereof |
| 09/14/2011 | CN102186482A Method for treating pulmonary arterial hypertension |
| 09/14/2011 | CN102186481A Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 09/14/2011 | CN102186480A Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid |
| 09/14/2011 | CN102186479A Aminopyrimidine inhibitors of histamine receptors for the treatment of disease |
| 09/14/2011 | CN102186478A Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 09/14/2011 | CN102186477A Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 09/14/2011 | CN102186476A Tryptophan hydroxylase inhibitors and methods of their use |
| 09/14/2011 | CN102186475A Novel inhibitors |
| 09/14/2011 | CN102186474A Uchida hiroshi [jp]; fukuda mamoru [jp]; aritomi seigo |
| 09/14/2011 | CN102186473A Compounds for the treatment of peripheral neuropathies |
| 09/14/2011 | CN102186472A Treatment |
| 09/14/2011 | CN102186471A Compositions and methods for influencing satiety, lipid metabolism, and fat utilization |
| 09/14/2011 | CN102186470A Topical nsaid compositions having sensate component |
| 09/14/2011 | CN102186469A Sustained release compositions comprising gums and sugar alcohols |
| 09/14/2011 | CN102186468A Urea-based film-forming solution for treating nail psoriasis |
| 09/14/2011 | CN102186467A Pharmaceutical compositions with attenuated release of phenolic opioids |
| 09/14/2011 | CN102186466A Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
| 09/14/2011 | CN102186465A Co-crystals of tramadol and nsaids |
| 09/14/2011 | CN102186464A Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis |
| 09/14/2011 | CN102186463A Nutritional composition to promote healthy development and growth |
| 09/14/2011 | CN102186460A Pharmaceutical topical compositions |
| 09/14/2011 | CN102186459A Composition containing ultra-micronized palmitoyl - ethanolamide |
| 09/14/2011 | CN102186458A Method for treatment of copd and other pulmonary diseases |
| 09/14/2011 | CN102186364A Concentrated liquid diet |
| 09/14/2011 | CN102186360A Nutritional composition with anti-regurgitation properties |
| 09/14/2011 | CN102186351A Pharmaceutical compositions and methods for stabilizing the same |
| 09/14/2011 | CN102186350A Compositions and methods of using (r)-pramipexole |
| 09/14/2011 | CN102183665A Method and apparatus for monitoring anti-platelet agents |
| 09/14/2011 | CN102183656A A method and kit for detecting the early onset of renal tubular cell injury |
| 09/14/2011 | CN102180941A Derivatives of betulonic acid, method for preparing same and application thereof |
| 09/14/2011 | CN102180928A 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof |
| 09/14/2011 | CN102180924A L-ribo-LNA analogues |
| 09/14/2011 | CN102180890A Cefathiamidine hydrate and preparation method and application thereof |
| 09/14/2011 | CN102180889A Ceftizoxime sodium crystalline hydrate and preparation method and application thereof |
| 09/14/2011 | CN102180882A Water-soluble porphyrin iron |